• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病瘦患者的特征:高血红蛋白水平的潜在作用。

Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.

作者信息

Akyuz Umit, Yesil Atakan, Yilmaz Yusuf

机构信息

Department of Gastroenterology, Medical Faculty, Yeditepe University , Istanbul , Turkey.

出版信息

Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.

DOI:10.3109/00365521.2014.983160
PMID:25540973
Abstract

OBJECTIVE

Overweight and obesity are major risk factors for the development of nonalcoholic fatty liver disease (NAFLD). However, a minority of NAFLD patients have a body mass index (BMI) <25 kg/m(2) (lean NAFLD). We sought to investigate whether significant differences exist between lean NAFLD and more common forms of NAFLD associated with overweight/obesity.

PATIENTS AND METHODS

A total of 483 consecutive patients with biopsy-proven NAFLD were enrolled. Lean NAFLD was defined as having a BMI <25 kg/m(2). We identified 37 patients with lean NAFLD (7.6%).

RESULTS

Compared with NAFLD patients with overweight/obesity, lean NAFLD patients were younger, had lower blood pressure values, higher levels of hemoglobin, a lower prevalence of the metabolic syndrome, and less severe hepatic fibrosis. In NAFLD patients with overweight/obesity, diabetes was the only independent predictor of nonalcoholic steatohepatitis (NASH). In lean NAFLD, the only variable independently associated with NASH was hemoglobin. Alanine aminotransferase and diabetes were independent predictors of fibrosis ≥2 in NAFLD patients with overweight/obesity, whereas hemoglobin was the only independent predictor of fibrosis ≥2 in lean NAFLD.

CONCLUSION

In summary, lean NAFLD patients are younger and show less severe hepatic fibrosis. However, such subjects have higher hemoglobin levels, which seem to predict the histological severity.

摘要

目的

超重和肥胖是非酒精性脂肪性肝病(NAFLD)发生的主要危险因素。然而,少数NAFLD患者的体重指数(BMI)<25 kg/m²(瘦型NAFLD)。我们试图研究瘦型NAFLD与超重/肥胖相关的更常见形式的NAFLD之间是否存在显著差异。

患者与方法

共纳入483例经活检证实为NAFLD的连续患者。瘦型NAFLD定义为BMI<25 kg/m²。我们确定了37例瘦型NAFLD患者(7.6%)。

结果

与超重/肥胖的NAFLD患者相比,瘦型NAFLD患者更年轻,血压值更低,血红蛋白水平更高,代谢综合征患病率更低,肝纤维化程度更轻。在超重/肥胖的NAFLD患者中,糖尿病是非酒精性脂肪性肝炎(NASH)的唯一独立预测因素。在瘦型NAFLD中,与NASH独立相关的唯一变量是血红蛋白。丙氨酸氨基转移酶和糖尿病是超重/肥胖的NAFLD患者纤维化≥2的独立预测因素,而血红蛋白是瘦型NAFLD患者纤维化≥2的唯一独立预测因素。

结论

总之,瘦型NAFLD患者更年轻,肝纤维化程度较轻。然而,这些患者的血红蛋白水平较高,这似乎可预测组织学严重程度。

相似文献

1
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征:高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.
2
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
3
The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.台湾地区体重指数对非酒精性脂肪性肝病临床病理特征的影响。
J Gastroenterol Hepatol. 2022 Oct;37(10):1901-1910. doi: 10.1111/jgh.15936. Epub 2022 Jul 13.
4
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
5
Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.系统评价与荟萃分析:非酒精性脂肪性肝病瘦型患者组织学疾病严重程度的意义。
Aliment Pharmacol Ther. 2018 Jan;47(1):16-25. doi: 10.1111/apt.14401. Epub 2017 Oct 30.
6
Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病的瘦、超重和肥胖患者中,肝脂肪变性和纤维化严重程度的不同预测因素。
Dig Liver Dis. 2019 Oct;51(10):1392-1399. doi: 10.1016/j.dld.2019.02.019. Epub 2019 Mar 28.
7
Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.非肥胖人群中非酒精性脂肪性肝病的临床特征。
Obes Facts. 2023;16(5):427-434. doi: 10.1159/000530845. Epub 2023 May 22.
8
The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的肝组织学病变严重程度与体重指数无关。
J Clin Gastroenterol. 2013 Mar;47(3):280-6. doi: 10.1097/MCG.0b013e31826be328.
9
Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.土耳其非酒精性脂肪性肝病负担日益加重:单中心经验
Turk J Gastroenterol. 2019 Oct;30(10):892-898. doi: 10.5152/tjg.2019.19072.
10
Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.瘦型非酒精性脂肪性肝病(NAFLD)患者的临床特征和代谢特征及其与肥胖和超重 NAFLD 的比较。
J Assoc Physicians India. 2022 Apr;70(4):11-12.

引用本文的文献

1
Predicting the risk of lean non-alcoholic fatty liver disease based on interpretable machine models in a Chinese T2DM population.基于可解释机器学习模型预测中国2型糖尿病患者发生瘦型非酒精性脂肪性肝病的风险
Front Endocrinol (Lausanne). 2025 Jul 11;16:1626203. doi: 10.3389/fendo.2025.1626203. eCollection 2025.
2
Linkage Between Hemoglobin to High Density Lipoprotein-Cholesterol Ratio and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationally Representative Study.血红蛋白与高密度脂蛋白胆固醇比值和代谢功能障碍相关脂肪性肝病之间的关联:一项全国代表性研究。
Clin Transl Sci. 2025 Jul;18(7):e70308. doi: 10.1111/cts.70308.
3
Nutraceutical Impact of Pumpkin Seed Oil on Expression Levels of EZH-2 and KRT-14 Genes against DSS-induced Inflammatory Bowel Disease in the Rat Model.
南瓜籽油对大鼠模型中硫酸葡聚糖钠诱导的炎症性肠病中EZH-2和KRT-14基因表达水平的营养保健作用
Cell Biochem Biophys. 2025 Jun;83(2):2185-2199. doi: 10.1007/s12013-024-01629-7. Epub 2025 Jan 27.
4
Central Obesity is an Independent Determinant of Advanced Fibrosis in Lean Patients With Nonalcoholic Fatty Liver Disease.中心性肥胖是非酒精性脂肪性肝病瘦患者发生高级纤维化的独立决定因素。
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102400. doi: 10.1016/j.jceh.2024.102400. Epub 2024 Aug 10.
5
Metabolic dysfunction associated fatty liver disease in healthy weight individuals.代谢功能障碍相关的健康体重个体的脂肪肝疾病。
Hepatol Int. 2024 Oct;18(Suppl 2):884-896. doi: 10.1007/s12072-024-10662-w. Epub 2024 Jul 25.
6
From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病:土耳其非酒精性脂肪性肝病患者代谢特征及代谢功能障碍相关脂肪性肝病潜在风险的荟萃分析与系统评价
Hepatol Forum. 2024 Jul 2;5(3):126-138. doi: 10.14744/hf.2023.2023.0042. eCollection 2024.
7
Update in lean metabolic dysfunction-associated steatotic liver disease.瘦素代谢功能障碍相关脂肪性肝病的最新进展。
World J Hepatol. 2024 Mar 27;16(3):452-464. doi: 10.4254/wjh.v16.i3.452.
8
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.
9
Metabolic characteristics of non-obese and obese metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus and its association with diabetic peripheral neuropathy and diabetic retinopathy.2型糖尿病中非肥胖和肥胖代谢功能障碍相关脂肪性肝病的代谢特征及其与糖尿病周围神经病变和糖尿病视网膜病变的关联
Front Med (Lausanne). 2023 Sep 27;10:1216412. doi: 10.3389/fmed.2023.1216412. eCollection 2023.
10
Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD.瘦的印度非酒精性脂肪性肝病 (NAFLD) 患者代谢危险因素较少,但与非瘦的 NAFLD 患者肝脏疾病严重程度相似。
Int J Obes (Lond). 2023 Oct;47(10):986-992. doi: 10.1038/s41366-023-01346-w. Epub 2023 Jul 20.